nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—epilepsy syndrome	0.208	0.44	CbGaD
Triamcinolone—NR3C1—epilepsy syndrome	0.169	0.357	CbGaD
Triamcinolone—PTGS2—epilepsy syndrome	0.0957	0.203	CbGaD
Triamcinolone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0231	0.0879	CbGbCtD
Triamcinolone—CYP3A4—Trimethadione—epilepsy syndrome	0.0214	0.0817	CbGbCtD
Triamcinolone—CYP3A4—Felbamate—epilepsy syndrome	0.0214	0.0817	CbGbCtD
Triamcinolone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0202	0.0768	CbGbCtD
Triamcinolone—CYP3A4—Clonazepam—epilepsy syndrome	0.0182	0.0694	CbGbCtD
Triamcinolone—CYP3A4—Clobazam—epilepsy syndrome	0.0175	0.0666	CbGbCtD
Triamcinolone—CYP3A4—Rufinamide—epilepsy syndrome	0.0149	0.0566	CbGbCtD
Triamcinolone—CYP3A4—Carbamazepine—epilepsy syndrome	0.0145	0.0552	CbGbCtD
Triamcinolone—CYP3A4—Primidone—epilepsy syndrome	0.0135	0.0515	CbGbCtD
Triamcinolone—CYP3A4—Phenytoin—epilepsy syndrome	0.013	0.0495	CbGbCtD
Triamcinolone—CYP3A4—Propofol—epilepsy syndrome	0.0121	0.0462	CbGbCtD
Triamcinolone—CYP3A4—Phenobarbital—epilepsy syndrome	0.0116	0.0441	CbGbCtD
Triamcinolone—CYP3A4—Acetazolamide—epilepsy syndrome	0.0116	0.0441	CbGbCtD
Triamcinolone—CYP3A4—Midazolam—epilepsy syndrome	0.0114	0.0435	CbGbCtD
Triamcinolone—CYP3A4—Diazepam—epilepsy syndrome	0.011	0.0418	CbGbCtD
Triamcinolone—CYP3A4—Zonisamide—epilepsy syndrome	0.0107	0.0408	CbGbCtD
Triamcinolone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00865	0.033	CbGbCtD
Triamcinolone—CYP3A4—Topiramate—epilepsy syndrome	0.0078	0.0297	CbGbCtD
Triamcinolone—SERPINA6—hindbrain—epilepsy syndrome	0.00149	0.12	CbGeAlD
Triamcinolone—NR3C1—hindbrain—epilepsy syndrome	0.000652	0.0528	CbGeAlD
Triamcinolone—SERPINA6—head—epilepsy syndrome	0.000472	0.0382	CbGeAlD
Triamcinolone—SERPINA6—nervous system—epilepsy syndrome	0.000447	0.0362	CbGeAlD
Triamcinolone—SERPINA6—central nervous system—epilepsy syndrome	0.00043	0.0348	CbGeAlD
Triamcinolone—SERPINA6—cerebellum—epilepsy syndrome	0.000421	0.034	CbGeAlD
Triamcinolone—BCHE—brainstem—epilepsy syndrome	0.00042	0.034	CbGeAlD
Triamcinolone—BCHE—forebrain—epilepsy syndrome	0.000405	0.0328	CbGeAlD
Triamcinolone—NR3C1—brainstem—epilepsy syndrome	0.000374	0.0302	CbGeAlD
Triamcinolone—BCHE—telencephalon—epilepsy syndrome	0.000373	0.0302	CbGeAlD
Triamcinolone—NR3C1—forebrain—epilepsy syndrome	0.000361	0.0292	CbGeAlD
Triamcinolone—SERPINA6—brain—epilepsy syndrome	0.000342	0.0277	CbGeAlD
Triamcinolone—NR3C1—telencephalon—epilepsy syndrome	0.000332	0.0268	CbGeAlD
Triamcinolone—PTGS2—forebrain—epilepsy syndrome	0.000312	0.0253	CbGeAlD
Triamcinolone—BCHE—medulla oblongata—epilepsy syndrome	0.000293	0.0237	CbGeAlD
Triamcinolone—PTGS2—telencephalon—epilepsy syndrome	0.000287	0.0232	CbGeAlD
Triamcinolone—BCHE—midbrain—epilepsy syndrome	0.000268	0.0217	CbGeAlD
Triamcinolone—BCHE—spinal cord—epilepsy syndrome	0.000261	0.0211	CbGeAlD
Triamcinolone—NR3C1—medulla oblongata—epilepsy syndrome	0.000261	0.0211	CbGeAlD
Triamcinolone—NR3C1—midbrain—epilepsy syndrome	0.000238	0.0193	CbGeAlD
Triamcinolone—NR3C1—spinal cord—epilepsy syndrome	0.000232	0.0188	CbGeAlD
Triamcinolone—BCHE—head—epilepsy syndrome	0.000232	0.0188	CbGeAlD
Triamcinolone—PTGS2—medulla oblongata—epilepsy syndrome	0.000226	0.0183	CbGeAlD
Triamcinolone—BCHE—nervous system—epilepsy syndrome	0.00022	0.0178	CbGeAlD
Triamcinolone—BCHE—central nervous system—epilepsy syndrome	0.000212	0.0171	CbGeAlD
Triamcinolone—BCHE—cerebellum—epilepsy syndrome	0.000207	0.0167	CbGeAlD
Triamcinolone—NR3C1—head—epilepsy syndrome	0.000207	0.0167	CbGeAlD
Triamcinolone—PTGS2—midbrain—epilepsy syndrome	0.000206	0.0167	CbGeAlD
Triamcinolone—PTGS2—spinal cord—epilepsy syndrome	0.000201	0.0163	CbGeAlD
Triamcinolone—NR3C1—nervous system—epilepsy syndrome	0.000196	0.0158	CbGeAlD
Triamcinolone—Prednisone—SLCO1A2—epilepsy syndrome	0.000194	0.0408	CrCbGaD
Triamcinolone—NR3C1—central nervous system—epilepsy syndrome	0.000189	0.0153	CbGeAlD
Triamcinolone—NR3C1—cerebellum—epilepsy syndrome	0.000184	0.0149	CbGeAlD
Triamcinolone—Prednisolone—SLCO1A2—epilepsy syndrome	0.000179	0.0376	CrCbGaD
Triamcinolone—PTGS2—head—epilepsy syndrome	0.000179	0.0145	CbGeAlD
Triamcinolone—PTGS2—nervous system—epilepsy syndrome	0.000169	0.0137	CbGeAlD
Triamcinolone—BCHE—brain—epilepsy syndrome	0.000168	0.0136	CbGeAlD
Triamcinolone—Difluprednate—NR3C1—epilepsy syndrome	0.000168	0.0354	CrCbGaD
Triamcinolone—PTGS2—central nervous system—epilepsy syndrome	0.000163	0.0132	CbGeAlD
Triamcinolone—Clocortolone—NR3C1—epilepsy syndrome	0.000163	0.0343	CrCbGaD
Triamcinolone—Prednicarbate—NR3C1—epilepsy syndrome	0.000163	0.0343	CrCbGaD
Triamcinolone—PTGS2—cerebellum—epilepsy syndrome	0.000159	0.0129	CbGeAlD
Triamcinolone—Diflorasone—NR3C1—epilepsy syndrome	0.000154	0.0324	CrCbGaD
Triamcinolone—Desonide—NR3C1—epilepsy syndrome	0.000154	0.0324	CrCbGaD
Triamcinolone—Desoximetasone—NR3C1—epilepsy syndrome	0.00015	0.0316	CrCbGaD
Triamcinolone—NR3C1—brain—epilepsy syndrome	0.00015	0.0121	CbGeAlD
Triamcinolone—Loteprednol—NR3C1—epilepsy syndrome	0.000149	0.0313	CrCbGaD
Triamcinolone—CYP3A4—nervous system—epilepsy syndrome	0.000148	0.012	CbGeAlD
Triamcinolone—CYP3A4—central nervous system—epilepsy syndrome	0.000143	0.0115	CbGeAlD
Triamcinolone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000137	0.0288	CrCbGaD
Triamcinolone—PTGS2—brain—epilepsy syndrome	0.00013	0.0105	CbGeAlD
Triamcinolone—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000129	0.0272	CrCbGaD
Triamcinolone—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.000127	0.0268	CrCbGaD
Triamcinolone—Budesonide—NR3C1—epilepsy syndrome	0.000118	0.0249	CrCbGaD
Triamcinolone—Amcinonide—NR3C1—epilepsy syndrome	0.000118	0.0249	CrCbGaD
Triamcinolone—Fluticasone furoate—NR3C1—epilepsy syndrome	0.000116	0.0244	CrCbGaD
Triamcinolone—Mometasone—NR3C1—epilepsy syndrome	0.000113	0.0237	CrCbGaD
Triamcinolone—Rimexolone—NR3C1—epilepsy syndrome	0.000111	0.0234	CrCbGaD
Triamcinolone—Fluocinonide—NR3C1—epilepsy syndrome	0.000105	0.0221	CrCbGaD
Triamcinolone—Beclomethasone—NR3C1—epilepsy syndrome	0.000105	0.0221	CrCbGaD
Triamcinolone—Alclometasone—NR3C1—epilepsy syndrome	0.000102	0.0215	CrCbGaD
Triamcinolone—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000102	0.0215	CrCbGaD
Triamcinolone—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000102	0.0215	CrCbGaD
Triamcinolone—Fludrocortisone—NR3C1—epilepsy syndrome	9.93e-05	0.0209	CrCbGaD
Triamcinolone—Flunisolide—NR3C1—epilepsy syndrome	9.93e-05	0.0209	CrCbGaD
Triamcinolone—Clobetasol propionate—NR3C1—epilepsy syndrome	9.93e-05	0.0209	CrCbGaD
Triamcinolone—Paramethasone—NR3C1—epilepsy syndrome	9.81e-05	0.0206	CrCbGaD
Triamcinolone—Fluorometholone—NR3C1—epilepsy syndrome	9.57e-05	0.0201	CrCbGaD
Triamcinolone—Methylprednisolone—NR3C1—epilepsy syndrome	9.25e-05	0.0195	CrCbGaD
Triamcinolone—Dexamethasone—CYP11A1—epilepsy syndrome	8.87e-05	0.0187	CrCbGaD
Triamcinolone—Fluoxymesterone—NR3C1—epilepsy syndrome	8.2e-05	0.0173	CrCbGaD
Triamcinolone—Dexamethasone—NOS2—epilepsy syndrome	7.35e-05	0.0155	CrCbGaD
Triamcinolone—Prednisone—NR3C1—epilepsy syndrome	7.08e-05	0.0149	CrCbGaD
Triamcinolone—Vomiting—Propofol—epilepsy syndrome	6.99e-05	0.000338	CcSEcCtD
Triamcinolone—Fluticasone Propionate—NR3C1—epilepsy syndrome	6.98e-05	0.0147	CrCbGaD
Triamcinolone—Pruritus—Diazepam—epilepsy syndrome	6.96e-05	0.000337	CcSEcCtD
Triamcinolone—Conjunctivitis—Topiramate—epilepsy syndrome	6.95e-05	0.000336	CcSEcCtD
Triamcinolone—Rash—Propofol—epilepsy syndrome	6.93e-05	0.000335	CcSEcCtD
Triamcinolone—Dermatitis—Propofol—epilepsy syndrome	6.92e-05	0.000335	CcSEcCtD
Triamcinolone—Hypertension—Valproic Acid—epilepsy syndrome	6.92e-05	0.000335	CcSEcCtD
Triamcinolone—Headache—Propofol—epilepsy syndrome	6.88e-05	0.000333	CcSEcCtD
Triamcinolone—Hypersensitivity—Zonisamide—epilepsy syndrome	6.86e-05	0.000332	CcSEcCtD
Triamcinolone—Vomiting—Midazolam—epilepsy syndrome	6.83e-05	0.000331	CcSEcCtD
Triamcinolone—Asthenia—Felbamate—epilepsy syndrome	6.83e-05	0.00033	CcSEcCtD
Triamcinolone—Myalgia—Valproic Acid—epilepsy syndrome	6.82e-05	0.00033	CcSEcCtD
Triamcinolone—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.78e-05	0.000328	CcSEcCtD
Triamcinolone—Rash—Midazolam—epilepsy syndrome	6.78e-05	0.000328	CcSEcCtD
Triamcinolone—Dizziness—Fosphenytoin—epilepsy syndrome	6.78e-05	0.000328	CcSEcCtD
Triamcinolone—Dermatitis—Midazolam—epilepsy syndrome	6.77e-05	0.000328	CcSEcCtD
Triamcinolone—Urticaria—Carbamazepine—epilepsy syndrome	6.76e-05	0.000327	CcSEcCtD
Triamcinolone—Vomiting—Levetiracetam—epilepsy syndrome	6.75e-05	0.000327	CcSEcCtD
Triamcinolone—Epistaxis—Topiramate—epilepsy syndrome	6.74e-05	0.000326	CcSEcCtD
Triamcinolone—Discomfort—Valproic Acid—epilepsy syndrome	6.74e-05	0.000326	CcSEcCtD
Triamcinolone—Headache—Midazolam—epilepsy syndrome	6.73e-05	0.000326	CcSEcCtD
Triamcinolone—Pruritus—Felbamate—epilepsy syndrome	6.73e-05	0.000326	CcSEcCtD
Triamcinolone—Body temperature increased—Carbamazepine—epilepsy syndrome	6.73e-05	0.000326	CcSEcCtD
Triamcinolone—Ill-defined disorder—Pregabalin—epilepsy syndrome	6.72e-05	0.000325	CcSEcCtD
Triamcinolone—Rash—Levetiracetam—epilepsy syndrome	6.69e-05	0.000324	CcSEcCtD
Triamcinolone—Dermatitis—Levetiracetam—epilepsy syndrome	6.69e-05	0.000324	CcSEcCtD
Triamcinolone—Asthenia—Zonisamide—epilepsy syndrome	6.68e-05	0.000323	CcSEcCtD
Triamcinolone—Dry mouth—Valproic Acid—epilepsy syndrome	6.67e-05	0.000323	CcSEcCtD
Triamcinolone—Headache—Levetiracetam—epilepsy syndrome	6.65e-05	0.000322	CcSEcCtD
Triamcinolone—Erythema—Gabapentin—epilepsy syndrome	6.64e-05	0.000321	CcSEcCtD
Triamcinolone—Angioedema—Pregabalin—epilepsy syndrome	6.62e-05	0.00032	CcSEcCtD
Triamcinolone—Hypersensitivity—Clonazepam—epilepsy syndrome	6.61e-05	0.00032	CcSEcCtD
Triamcinolone—Dizziness—Vigabatrin—epilepsy syndrome	6.6e-05	0.00032	CcSEcCtD
Triamcinolone—Pruritus—Zonisamide—epilepsy syndrome	6.59e-05	0.000319	CcSEcCtD
Triamcinolone—Hypersensitivity—Phenytoin—epilepsy syndrome	6.57e-05	0.000318	CcSEcCtD
Triamcinolone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.54e-05	0.000316	CcSEcCtD
Triamcinolone—Oedema—Valproic Acid—epilepsy syndrome	6.54e-05	0.000316	CcSEcCtD
Triamcinolone—Urticaria—Lamotrigine—epilepsy syndrome	6.54e-05	0.000316	CcSEcCtD
Triamcinolone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.54e-05	0.000316	CcSEcCtD
Triamcinolone—Bradycardia—Topiramate—epilepsy syndrome	6.53e-05	0.000316	CcSEcCtD
Triamcinolone—Malaise—Pregabalin—epilepsy syndrome	6.53e-05	0.000316	CcSEcCtD
Triamcinolone—Nausea—Propofol—epilepsy syndrome	6.53e-05	0.000316	CcSEcCtD
Triamcinolone—Prednisolone—NR3C1—epilepsy syndrome	6.52e-05	0.0137	CrCbGaD
Triamcinolone—Vomiting—Fosphenytoin—epilepsy syndrome	6.51e-05	0.000315	CcSEcCtD
Triamcinolone—Vertigo—Pregabalin—epilepsy syndrome	6.51e-05	0.000315	CcSEcCtD
Triamcinolone—Body temperature increased—Lamotrigine—epilepsy syndrome	6.5e-05	0.000315	CcSEcCtD
Triamcinolone—Dysgeusia—Gabapentin—epilepsy syndrome	6.5e-05	0.000315	CcSEcCtD
Triamcinolone—Dizziness—Diazepam—epilepsy syndrome	6.5e-05	0.000315	CcSEcCtD
Triamcinolone—Infection—Valproic Acid—epilepsy syndrome	6.49e-05	0.000314	CcSEcCtD
Triamcinolone—Syncope—Pregabalin—epilepsy syndrome	6.49e-05	0.000314	CcSEcCtD
Triamcinolone—Rash—Fosphenytoin—epilepsy syndrome	6.46e-05	0.000313	CcSEcCtD
Triamcinolone—Dermatitis—Fosphenytoin—epilepsy syndrome	6.45e-05	0.000312	CcSEcCtD
Triamcinolone—Prednisone—CYP2C19—epilepsy syndrome	6.45e-05	0.0136	CrCbGaD
Triamcinolone—Haemoglobin—Topiramate—epilepsy syndrome	6.45e-05	0.000312	CcSEcCtD
Triamcinolone—Asthenia—Clonazepam—epilepsy syndrome	6.44e-05	0.000312	CcSEcCtD
Triamcinolone—Rhinitis—Topiramate—epilepsy syndrome	6.43e-05	0.000311	CcSEcCtD
Triamcinolone—Back pain—Gabapentin—epilepsy syndrome	6.42e-05	0.000311	CcSEcCtD
Triamcinolone—Headache—Fosphenytoin—epilepsy syndrome	6.42e-05	0.000311	CcSEcCtD
Triamcinolone—Haemorrhage—Topiramate—epilepsy syndrome	6.42e-05	0.00031	CcSEcCtD
Triamcinolone—Asthenia—Phenytoin—epilepsy syndrome	6.4e-05	0.00031	CcSEcCtD
Triamcinolone—Betamethasone—NR3C1—epilepsy syndrome	6.39e-05	0.0135	CrCbGaD
Triamcinolone—Nausea—Midazolam—epilepsy syndrome	6.39e-05	0.000309	CcSEcCtD
Triamcinolone—Tachycardia—Valproic Acid—epilepsy syndrome	6.38e-05	0.000309	CcSEcCtD
Triamcinolone—Pharyngitis—Topiramate—epilepsy syndrome	6.37e-05	0.000308	CcSEcCtD
Triamcinolone—Loss of consciousness—Pregabalin—epilepsy syndrome	6.36e-05	0.000308	CcSEcCtD
Triamcinolone—Asthenia—Oxcarbazepine—epilepsy syndrome	6.36e-05	0.000308	CcSEcCtD
Triamcinolone—Pruritus—Clonazepam—epilepsy syndrome	6.35e-05	0.000307	CcSEcCtD
Triamcinolone—Vomiting—Vigabatrin—epilepsy syndrome	6.35e-05	0.000307	CcSEcCtD
Triamcinolone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.32e-05	0.000306	CcSEcCtD
Triamcinolone—Cough—Pregabalin—epilepsy syndrome	6.32e-05	0.000306	CcSEcCtD
Triamcinolone—Pruritus—Phenytoin—epilepsy syndrome	6.31e-05	0.000305	CcSEcCtD
Triamcinolone—Nausea—Levetiracetam—epilepsy syndrome	6.31e-05	0.000305	CcSEcCtD
Triamcinolone—Rash—Vigabatrin—epilepsy syndrome	6.3e-05	0.000305	CcSEcCtD
Triamcinolone—Dizziness—Felbamate—epilepsy syndrome	6.29e-05	0.000304	CcSEcCtD
Triamcinolone—Dermatitis—Vigabatrin—epilepsy syndrome	6.29e-05	0.000304	CcSEcCtD
Triamcinolone—Pruritus—Oxcarbazepine—epilepsy syndrome	6.28e-05	0.000304	CcSEcCtD
Triamcinolone—Convulsion—Pregabalin—epilepsy syndrome	6.27e-05	0.000304	CcSEcCtD
Triamcinolone—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.27e-05	0.000303	CcSEcCtD
Triamcinolone—Headache—Vigabatrin—epilepsy syndrome	6.26e-05	0.000303	CcSEcCtD
Triamcinolone—Hypertension—Pregabalin—epilepsy syndrome	6.25e-05	0.000302	CcSEcCtD
Triamcinolone—Vomiting—Diazepam—epilepsy syndrome	6.25e-05	0.000302	CcSEcCtD
Triamcinolone—Rash—Diazepam—epilepsy syndrome	6.2e-05	0.0003	CcSEcCtD
Triamcinolone—Dermatitis—Diazepam—epilepsy syndrome	6.19e-05	0.0003	CcSEcCtD
Triamcinolone—Myalgia—Pregabalin—epilepsy syndrome	6.16e-05	0.000298	CcSEcCtD
Triamcinolone—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.16e-05	0.000298	CcSEcCtD
Triamcinolone—Dizziness—Zonisamide—epilepsy syndrome	6.16e-05	0.000298	CcSEcCtD
Triamcinolone—Headache—Diazepam—epilepsy syndrome	6.16e-05	0.000298	CcSEcCtD
Triamcinolone—Asthenia—Carbamazepine—epilepsy syndrome	6.11e-05	0.000295	CcSEcCtD
Triamcinolone—Discomfort—Pregabalin—epilepsy syndrome	6.09e-05	0.000295	CcSEcCtD
Triamcinolone—Nausea—Fosphenytoin—epilepsy syndrome	6.09e-05	0.000294	CcSEcCtD
Triamcinolone—Angioedema—Gabapentin—epilepsy syndrome	6.07e-05	0.000294	CcSEcCtD
Triamcinolone—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.06e-05	0.000293	CcSEcCtD
Triamcinolone—Vomiting—Felbamate—epilepsy syndrome	6.05e-05	0.000293	CcSEcCtD
Triamcinolone—Dry mouth—Pregabalin—epilepsy syndrome	6.03e-05	0.000292	CcSEcCtD
Triamcinolone—Pruritus—Carbamazepine—epilepsy syndrome	6.02e-05	0.000291	CcSEcCtD
Triamcinolone—Rash—Felbamate—epilepsy syndrome	6e-05	0.00029	CcSEcCtD
Triamcinolone—Dermatitis—Felbamate—epilepsy syndrome	5.99e-05	0.00029	CcSEcCtD
Triamcinolone—Malaise—Gabapentin—epilepsy syndrome	5.99e-05	0.00029	CcSEcCtD
Triamcinolone—Vertigo—Gabapentin—epilepsy syndrome	5.97e-05	0.000289	CcSEcCtD
Triamcinolone—Headache—Felbamate—epilepsy syndrome	5.96e-05	0.000288	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.96e-05	0.000288	CcSEcCtD
Triamcinolone—Syncope—Gabapentin—epilepsy syndrome	5.95e-05	0.000288	CcSEcCtD
Triamcinolone—Dizziness—Clonazepam—epilepsy syndrome	5.94e-05	0.000287	CcSEcCtD
Triamcinolone—Nausea—Vigabatrin—epilepsy syndrome	5.93e-05	0.000287	CcSEcCtD
Triamcinolone—Vomiting—Zonisamide—epilepsy syndrome	5.92e-05	0.000287	CcSEcCtD
Triamcinolone—Insomnia—Valproic Acid—epilepsy syndrome	5.91e-05	0.000286	CcSEcCtD
Triamcinolone—Oedema—Pregabalin—epilepsy syndrome	5.91e-05	0.000286	CcSEcCtD
Triamcinolone—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.91e-05	0.000286	CcSEcCtD
Triamcinolone—Asthenia—Lamotrigine—epilepsy syndrome	5.9e-05	0.000286	CcSEcCtD
Triamcinolone—Dizziness—Phenytoin—epilepsy syndrome	5.9e-05	0.000285	CcSEcCtD
Triamcinolone—Rash—Zonisamide—epilepsy syndrome	5.87e-05	0.000284	CcSEcCtD
Triamcinolone—Infection—Pregabalin—epilepsy syndrome	5.87e-05	0.000284	CcSEcCtD
Triamcinolone—Paraesthesia—Valproic Acid—epilepsy syndrome	5.87e-05	0.000284	CcSEcCtD
Triamcinolone—Dermatitis—Zonisamide—epilepsy syndrome	5.87e-05	0.000284	CcSEcCtD
Triamcinolone—Dizziness—Oxcarbazepine—epilepsy syndrome	5.87e-05	0.000284	CcSEcCtD
Triamcinolone—Nausea—Diazepam—epilepsy syndrome	5.84e-05	0.000283	CcSEcCtD
Triamcinolone—Loss of consciousness—Gabapentin—epilepsy syndrome	5.84e-05	0.000282	CcSEcCtD
Triamcinolone—Headache—Zonisamide—epilepsy syndrome	5.84e-05	0.000282	CcSEcCtD
Triamcinolone—Dyspnoea—Valproic Acid—epilepsy syndrome	5.83e-05	0.000282	CcSEcCtD
Triamcinolone—Pruritus—Lamotrigine—epilepsy syndrome	5.82e-05	0.000282	CcSEcCtD
Triamcinolone—Shock—Pregabalin—epilepsy syndrome	5.81e-05	0.000281	CcSEcCtD
Triamcinolone—Cough—Gabapentin—epilepsy syndrome	5.79e-05	0.00028	CcSEcCtD
Triamcinolone—Hydrocortisone—ABCG2—epilepsy syndrome	5.78e-05	0.0122	CrCbGaD
Triamcinolone—Tachycardia—Pregabalin—epilepsy syndrome	5.77e-05	0.000279	CcSEcCtD
Triamcinolone—Dyspepsia—Valproic Acid—epilepsy syndrome	5.75e-05	0.000278	CcSEcCtD
Triamcinolone—Convulsion—Gabapentin—epilepsy syndrome	5.75e-05	0.000278	CcSEcCtD
Triamcinolone—Hypertension—Gabapentin—epilepsy syndrome	5.73e-05	0.000277	CcSEcCtD
Triamcinolone—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.71e-05	0.000276	CcSEcCtD
Triamcinolone—Vomiting—Clonazepam—epilepsy syndrome	5.71e-05	0.000276	CcSEcCtD
Triamcinolone—Vomiting—Phenytoin—epilepsy syndrome	5.67e-05	0.000274	CcSEcCtD
Triamcinolone—Rash—Clonazepam—epilepsy syndrome	5.66e-05	0.000274	CcSEcCtD
Triamcinolone—Dermatitis—Clonazepam—epilepsy syndrome	5.66e-05	0.000274	CcSEcCtD
Triamcinolone—Myalgia—Gabapentin—epilepsy syndrome	5.65e-05	0.000273	CcSEcCtD
Triamcinolone—Nausea—Felbamate—epilepsy syndrome	5.65e-05	0.000273	CcSEcCtD
Triamcinolone—Vomiting—Oxcarbazepine—epilepsy syndrome	5.64e-05	0.000273	CcSEcCtD
Triamcinolone—Fatigue—Valproic Acid—epilepsy syndrome	5.64e-05	0.000273	CcSEcCtD
Triamcinolone—Dizziness—Carbamazepine—epilepsy syndrome	5.63e-05	0.000272	CcSEcCtD
Triamcinolone—Headache—Clonazepam—epilepsy syndrome	5.62e-05	0.000272	CcSEcCtD
Triamcinolone—Rash—Phenytoin—epilepsy syndrome	5.62e-05	0.000272	CcSEcCtD
Triamcinolone—Dermatitis—Phenytoin—epilepsy syndrome	5.62e-05	0.000272	CcSEcCtD
Triamcinolone—Fluticasone furoate—ABCB1—epilepsy syndrome	5.6e-05	0.0118	CrCbGaD
Triamcinolone—Rash—Oxcarbazepine—epilepsy syndrome	5.59e-05	0.000271	CcSEcCtD
Triamcinolone—Pain—Valproic Acid—epilepsy syndrome	5.59e-05	0.00027	CcSEcCtD
Triamcinolone—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.59e-05	0.00027	CcSEcCtD
Triamcinolone—Headache—Phenytoin—epilepsy syndrome	5.59e-05	0.00027	CcSEcCtD
Triamcinolone—Erythema—Topiramate—epilepsy syndrome	5.59e-05	0.00027	CcSEcCtD
Triamcinolone—Discomfort—Gabapentin—epilepsy syndrome	5.59e-05	0.00027	CcSEcCtD
Triamcinolone—Headache—Oxcarbazepine—epilepsy syndrome	5.56e-05	0.000269	CcSEcCtD
Triamcinolone—Nausea—Zonisamide—epilepsy syndrome	5.53e-05	0.000268	CcSEcCtD
Triamcinolone—Dry mouth—Gabapentin—epilepsy syndrome	5.53e-05	0.000267	CcSEcCtD
Triamcinolone—Dysgeusia—Topiramate—epilepsy syndrome	5.47e-05	0.000265	CcSEcCtD
Triamcinolone—Dizziness—Lamotrigine—epilepsy syndrome	5.44e-05	0.000263	CcSEcCtD
Triamcinolone—Oedema—Gabapentin—epilepsy syndrome	5.42e-05	0.000262	CcSEcCtD
Triamcinolone—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.42e-05	0.000262	CcSEcCtD
Triamcinolone—Vomiting—Carbamazepine—epilepsy syndrome	5.41e-05	0.000262	CcSEcCtD
Triamcinolone—Back pain—Topiramate—epilepsy syndrome	5.4e-05	0.000261	CcSEcCtD
Triamcinolone—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.39e-05	0.000261	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.38e-05	0.00026	CcSEcCtD
Triamcinolone—Infection—Gabapentin—epilepsy syndrome	5.38e-05	0.00026	CcSEcCtD
Triamcinolone—Rash—Carbamazepine—epilepsy syndrome	5.37e-05	0.00026	CcSEcCtD
Triamcinolone—Dermatitis—Carbamazepine—epilepsy syndrome	5.36e-05	0.000259	CcSEcCtD
Triamcinolone—Insomnia—Pregabalin—epilepsy syndrome	5.35e-05	0.000259	CcSEcCtD
Triamcinolone—Nausea—Clonazepam—epilepsy syndrome	5.33e-05	0.000258	CcSEcCtD
Triamcinolone—Headache—Carbamazepine—epilepsy syndrome	5.33e-05	0.000258	CcSEcCtD
Triamcinolone—Shock—Gabapentin—epilepsy syndrome	5.33e-05	0.000258	CcSEcCtD
Triamcinolone—Paraesthesia—Pregabalin—epilepsy syndrome	5.31e-05	0.000257	CcSEcCtD
Triamcinolone—Nausea—Phenytoin—epilepsy syndrome	5.3e-05	0.000256	CcSEcCtD
Triamcinolone—Tachycardia—Gabapentin—epilepsy syndrome	5.29e-05	0.000256	CcSEcCtD
Triamcinolone—Dyspnoea—Pregabalin—epilepsy syndrome	5.27e-05	0.000255	CcSEcCtD
Triamcinolone—Nausea—Oxcarbazepine—epilepsy syndrome	5.27e-05	0.000255	CcSEcCtD
Triamcinolone—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.24e-05	0.000253	CcSEcCtD
Triamcinolone—Vomiting—Lamotrigine—epilepsy syndrome	5.23e-05	0.000253	CcSEcCtD
Triamcinolone—Urticaria—Valproic Acid—epilepsy syndrome	5.19e-05	0.000251	CcSEcCtD
Triamcinolone—Rash—Lamotrigine—epilepsy syndrome	5.19e-05	0.000251	CcSEcCtD
Triamcinolone—Ill-defined disorder—Topiramate—epilepsy syndrome	5.18e-05	0.000251	CcSEcCtD
Triamcinolone—Dermatitis—Lamotrigine—epilepsy syndrome	5.18e-05	0.000251	CcSEcCtD
Triamcinolone—Body temperature increased—Valproic Acid—epilepsy syndrome	5.17e-05	0.00025	CcSEcCtD
Triamcinolone—Headache—Lamotrigine—epilepsy syndrome	5.15e-05	0.000249	CcSEcCtD
Triamcinolone—Fatigue—Pregabalin—epilepsy syndrome	5.1e-05	0.000247	CcSEcCtD
Triamcinolone—Nausea—Carbamazepine—epilepsy syndrome	5.06e-05	0.000245	CcSEcCtD
Triamcinolone—Pain—Pregabalin—epilepsy syndrome	5.05e-05	0.000245	CcSEcCtD
Triamcinolone—Malaise—Topiramate—epilepsy syndrome	5.04e-05	0.000244	CcSEcCtD
Triamcinolone—Vertigo—Topiramate—epilepsy syndrome	5.02e-05	0.000243	CcSEcCtD
Triamcinolone—Syncope—Topiramate—epilepsy syndrome	5.01e-05	0.000242	CcSEcCtD
Triamcinolone—Hydrocortisone—NR3C1—epilepsy syndrome	4.99e-05	0.0105	CrCbGaD
Triamcinolone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.94e-05	0.000239	CcSEcCtD
Triamcinolone—Loss of consciousness—Topiramate—epilepsy syndrome	4.91e-05	0.000238	CcSEcCtD
Triamcinolone—Insomnia—Gabapentin—epilepsy syndrome	4.9e-05	0.000237	CcSEcCtD
Triamcinolone—Nausea—Lamotrigine—epilepsy syndrome	4.89e-05	0.000236	CcSEcCtD
Triamcinolone—Dexamethasone—ABCC2—epilepsy syndrome	4.88e-05	0.0103	CrCbGaD
Triamcinolone—Cough—Topiramate—epilepsy syndrome	4.87e-05	0.000236	CcSEcCtD
Triamcinolone—Feeling abnormal—Pregabalin—epilepsy syndrome	4.87e-05	0.000236	CcSEcCtD
Triamcinolone—Paraesthesia—Gabapentin—epilepsy syndrome	4.87e-05	0.000235	CcSEcCtD
Triamcinolone—Convulsion—Topiramate—epilepsy syndrome	4.84e-05	0.000234	CcSEcCtD
Triamcinolone—Dyspnoea—Gabapentin—epilepsy syndrome	4.83e-05	0.000234	CcSEcCtD
Triamcinolone—Hypertension—Topiramate—epilepsy syndrome	4.82e-05	0.000233	CcSEcCtD
Triamcinolone—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.82e-05	0.000233	CcSEcCtD
Triamcinolone—Dyspepsia—Gabapentin—epilepsy syndrome	4.77e-05	0.000231	CcSEcCtD
Triamcinolone—Myalgia—Topiramate—epilepsy syndrome	4.76e-05	0.00023	CcSEcCtD
Triamcinolone—Discomfort—Topiramate—epilepsy syndrome	4.7e-05	0.000227	CcSEcCtD
Triamcinolone—Urticaria—Pregabalin—epilepsy syndrome	4.69e-05	0.000227	CcSEcCtD
Triamcinolone—Asthenia—Valproic Acid—epilepsy syndrome	4.69e-05	0.000227	CcSEcCtD
Triamcinolone—Fatigue—Gabapentin—epilepsy syndrome	4.67e-05	0.000226	CcSEcCtD
Triamcinolone—Body temperature increased—Pregabalin—epilepsy syndrome	4.67e-05	0.000226	CcSEcCtD
Triamcinolone—Dry mouth—Topiramate—epilepsy syndrome	4.65e-05	0.000225	CcSEcCtD
Triamcinolone—Pain—Gabapentin—epilepsy syndrome	4.63e-05	0.000224	CcSEcCtD
Triamcinolone—Pruritus—Valproic Acid—epilepsy syndrome	4.62e-05	0.000224	CcSEcCtD
Triamcinolone—Oedema—Topiramate—epilepsy syndrome	4.56e-05	0.000221	CcSEcCtD
Triamcinolone—Infection—Topiramate—epilepsy syndrome	4.53e-05	0.000219	CcSEcCtD
Triamcinolone—Shock—Topiramate—epilepsy syndrome	4.49e-05	0.000217	CcSEcCtD
Triamcinolone—Feeling abnormal—Gabapentin—epilepsy syndrome	4.47e-05	0.000216	CcSEcCtD
Triamcinolone—Methylprednisolone—ABCB1—epilepsy syndrome	4.47e-05	0.0094	CrCbGaD
Triamcinolone—Tachycardia—Topiramate—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Triamcinolone—Hyperhidrosis—Topiramate—epilepsy syndrome	4.41e-05	0.000213	CcSEcCtD
Triamcinolone—Hypersensitivity—Pregabalin—epilepsy syndrome	4.35e-05	0.000211	CcSEcCtD
Triamcinolone—Dizziness—Valproic Acid—epilepsy syndrome	4.32e-05	0.000209	CcSEcCtD
Triamcinolone—Dexamethasone—ABCG2—epilepsy syndrome	4.31e-05	0.00907	CrCbGaD
Triamcinolone—Urticaria—Gabapentin—epilepsy syndrome	4.3e-05	0.000208	CcSEcCtD
Triamcinolone—Body temperature increased—Gabapentin—epilepsy syndrome	4.28e-05	0.000207	CcSEcCtD
Triamcinolone—Asthenia—Pregabalin—epilepsy syndrome	4.24e-05	0.000205	CcSEcCtD
Triamcinolone—Pruritus—Pregabalin—epilepsy syndrome	4.18e-05	0.000202	CcSEcCtD
Triamcinolone—Vomiting—Valproic Acid—epilepsy syndrome	4.16e-05	0.000201	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.15e-05	0.000201	CcSEcCtD
Triamcinolone—Insomnia—Topiramate—epilepsy syndrome	4.12e-05	0.0002	CcSEcCtD
Triamcinolone—Rash—Valproic Acid—epilepsy syndrome	4.12e-05	0.000199	CcSEcCtD
Triamcinolone—Dermatitis—Valproic Acid—epilepsy syndrome	4.12e-05	0.000199	CcSEcCtD
Triamcinolone—Headache—Valproic Acid—epilepsy syndrome	4.1e-05	0.000198	CcSEcCtD
Triamcinolone—Paraesthesia—Topiramate—epilepsy syndrome	4.09e-05	0.000198	CcSEcCtD
Triamcinolone—Dyspnoea—Topiramate—epilepsy syndrome	4.06e-05	0.000197	CcSEcCtD
Triamcinolone—Dyspepsia—Topiramate—epilepsy syndrome	4.01e-05	0.000194	CcSEcCtD
Triamcinolone—Hypersensitivity—Gabapentin—epilepsy syndrome	3.99e-05	0.000193	CcSEcCtD
Triamcinolone—Fatigue—Topiramate—epilepsy syndrome	3.93e-05	0.00019	CcSEcCtD
Triamcinolone—Dizziness—Pregabalin—epilepsy syndrome	3.91e-05	0.000189	CcSEcCtD
Triamcinolone—Pain—Topiramate—epilepsy syndrome	3.9e-05	0.000189	CcSEcCtD
Triamcinolone—Asthenia—Gabapentin—epilepsy syndrome	3.89e-05	0.000188	CcSEcCtD
Triamcinolone—Nausea—Valproic Acid—epilepsy syndrome	3.88e-05	0.000188	CcSEcCtD
Triamcinolone—Pruritus—Gabapentin—epilepsy syndrome	3.83e-05	0.000185	CcSEcCtD
Triamcinolone—Vomiting—Pregabalin—epilepsy syndrome	3.76e-05	0.000182	CcSEcCtD
Triamcinolone—Feeling abnormal—Topiramate—epilepsy syndrome	3.76e-05	0.000182	CcSEcCtD
Triamcinolone—Rash—Pregabalin—epilepsy syndrome	3.73e-05	0.00018	CcSEcCtD
Triamcinolone—Dermatitis—Pregabalin—epilepsy syndrome	3.72e-05	0.00018	CcSEcCtD
Triamcinolone—Dexamethasone—NR3C1—epilepsy syndrome	3.72e-05	0.00782	CrCbGaD
Triamcinolone—Headache—Pregabalin—epilepsy syndrome	3.7e-05	0.000179	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—epilepsy syndrome	3.63e-05	0.00763	CrCbGaD
Triamcinolone—Urticaria—Topiramate—epilepsy syndrome	3.62e-05	0.000175	CcSEcCtD
Triamcinolone—Body temperature increased—Topiramate—epilepsy syndrome	3.6e-05	0.000174	CcSEcCtD
Triamcinolone—Dizziness—Gabapentin—epilepsy syndrome	3.58e-05	0.000173	CcSEcCtD
Triamcinolone—Prednisone—ALB—epilepsy syndrome	3.58e-05	0.00753	CrCbGaD
Triamcinolone—Nausea—Pregabalin—epilepsy syndrome	3.51e-05	0.00017	CcSEcCtD
Triamcinolone—Vomiting—Gabapentin—epilepsy syndrome	3.45e-05	0.000167	CcSEcCtD
Triamcinolone—Rash—Gabapentin—epilepsy syndrome	3.42e-05	0.000165	CcSEcCtD
Triamcinolone—Prednisone—ABCB1—epilepsy syndrome	3.42e-05	0.00719	CrCbGaD
Triamcinolone—Dermatitis—Gabapentin—epilepsy syndrome	3.41e-05	0.000165	CcSEcCtD
Triamcinolone—Headache—Gabapentin—epilepsy syndrome	3.39e-05	0.000164	CcSEcCtD
Triamcinolone—Dexamethasone—CYP2C19—epilepsy syndrome	3.39e-05	0.00713	CrCbGaD
Triamcinolone—Hypersensitivity—Topiramate—epilepsy syndrome	3.36e-05	0.000163	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.29e-05	0.000792	CbGpPWpGaD
Triamcinolone—Asthenia—Topiramate—epilepsy syndrome	3.27e-05	0.000158	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.27e-05	0.000788	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.25e-05	0.000782	CbGpPWpGaD
Triamcinolone—Pruritus—Topiramate—epilepsy syndrome	3.23e-05	0.000156	CcSEcCtD
Triamcinolone—Nausea—Gabapentin—epilepsy syndrome	3.22e-05	0.000156	CcSEcCtD
Triamcinolone—Prednisolone—ABCB1—epilepsy syndrome	3.15e-05	0.00663	CrCbGaD
Triamcinolone—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	3.14e-05	0.000757	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SV2A—epilepsy syndrome	3.1e-05	0.000748	CbGpPWpGaD
Triamcinolone—Betamethasone—ABCB1—epilepsy syndrome	3.08e-05	0.00649	CrCbGaD
Triamcinolone—BCHE—Metabolism—UPB1—epilepsy syndrome	3.08e-05	0.000742	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NEU1—epilepsy syndrome	3.08e-05	0.000742	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ATIC—epilepsy syndrome	3.08e-05	0.000742	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FAR1—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADK—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CERS1—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GLUD1—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PDXK—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	3.06e-05	0.000736	CbGpPWpGaD
Triamcinolone—Dizziness—Topiramate—epilepsy syndrome	3.01e-05	0.000146	CcSEcCtD
Triamcinolone—BCHE—Metabolism—HSD17B4—epilepsy syndrome	2.96e-05	0.000714	CbGpPWpGaD
Triamcinolone—Vomiting—Topiramate—epilepsy syndrome	2.9e-05	0.00014	CcSEcCtD
Triamcinolone—Rash—Topiramate—epilepsy syndrome	2.87e-05	0.000139	CcSEcCtD
Triamcinolone—Dermatitis—Topiramate—epilepsy syndrome	2.87e-05	0.000139	CcSEcCtD
Triamcinolone—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	2.86e-05	0.000689	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPP1R3C—epilepsy syndrome	2.86e-05	0.000689	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GBE1—epilepsy syndrome	2.86e-05	0.000689	CbGpPWpGaD
Triamcinolone—Headache—Topiramate—epilepsy syndrome	2.86e-05	0.000138	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	2.84e-05	0.000685	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TFAM—epilepsy syndrome	2.84e-05	0.000685	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACTB—epilepsy syndrome	2.81e-05	0.000676	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—PRKCB—epilepsy syndrome	2.81e-05	0.000676	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GAMT—epilepsy syndrome	2.8e-05	0.000674	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—EPM2A—epilepsy syndrome	2.8e-05	0.000674	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PNPO—epilepsy syndrome	2.8e-05	0.000674	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	2.8e-05	0.000674	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PFKL—epilepsy syndrome	2.77e-05	0.000666	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.74e-05	0.000661	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.74e-05	0.000659	CbGpPWpGaD
Triamcinolone—Nausea—Topiramate—epilepsy syndrome	2.71e-05	0.000131	CcSEcCtD
Triamcinolone—BCHE—Metabolism—ASAH1—epilepsy syndrome	2.69e-05	0.000648	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.67e-05	0.000643	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.66e-05	0.00064	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.63e-05	0.000633	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—STXBP1—epilepsy syndrome	2.62e-05	0.000631	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.6e-05	0.000626	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.6e-05	0.000626	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA4—epilepsy syndrome	2.6e-05	0.000626	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.59e-05	0.000625	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.58e-05	0.00062	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.56e-05	0.000617	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NT5E—epilepsy syndrome	2.55e-05	0.000615	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALAD—epilepsy syndrome	2.55e-05	0.000615	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.54e-05	0.000612	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STX1B—epilepsy syndrome	2.53e-05	0.00061	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.53e-05	0.000608	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP2D6—epilepsy syndrome	2.51e-05	0.00529	CrCbGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	2.5e-05	0.000603	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	2.48e-05	0.000597	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	2.45e-05	0.000591	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.45e-05	0.00059	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—COX3—epilepsy syndrome	2.44e-05	0.000589	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALDH7A1—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CACNA1A—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Triamcinolone—Hydrocortisone—ABCB1—epilepsy syndrome	2.41e-05	0.00507	CrCbGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.39e-05	0.000575	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ST3GAL3—epilepsy syndrome	2.38e-05	0.000574	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CPSF4—epilepsy syndrome	2.35e-05	0.000567	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GBE1—epilepsy syndrome	2.35e-05	0.000567	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.35e-05	0.000567	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ADSL—epilepsy syndrome	2.33e-05	0.000562	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.33e-05	0.000562	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.32e-05	0.00056	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.32e-05	0.000558	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.32e-05	0.000558	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.32e-05	0.000558	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.32e-05	0.000558	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.32e-05	0.000558	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.31e-05	0.000556	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—epilepsy syndrome	2.3e-05	0.000555	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GLUL—epilepsy syndrome	2.29e-05	0.000551	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.28e-05	0.000549	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	2.27e-05	0.000547	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.27e-05	0.000545	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.25e-05	0.000542	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CACNA1D—epilepsy syndrome	2.25e-05	0.000541	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.13e-05	0.000513	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.12e-05	0.00051	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.12e-05	0.00051	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.12e-05	0.00051	CbGpPWpGaD
Triamcinolone—Dexamethasone—PTGS2—epilepsy syndrome	2.11e-05	0.00444	CrCbGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.11e-05	0.000508	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PLAUR—epilepsy syndrome	2.1e-05	0.000507	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TXNRD1—epilepsy syndrome	2.1e-05	0.000506	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	2.04e-05	0.000491	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AQP1—epilepsy syndrome	2.04e-05	0.000491	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	2e-05	0.000482	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.99e-05	0.00048	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.97e-05	0.000475	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.97e-05	0.000475	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.96e-05	0.000472	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.96e-05	0.000471	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.93e-05	0.000464	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.89e-05	0.000454	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.85e-05	0.000446	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CHRM3—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—KCNJ11—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.8e-05	0.000434	CbGpPWpGaD
Triamcinolone—Dexamethasone—ABCB1—epilepsy syndrome	1.79e-05	0.00378	CrCbGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.76e-05	0.000425	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.76e-05	0.000424	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.76e-05	0.000423	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.76e-05	0.000423	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.72e-05	0.000414	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.71e-05	0.000413	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.71e-05	0.000412	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.68e-05	0.000405	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.68e-05	0.000403	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.68e-05	0.000403	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.65e-05	0.000398	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.64e-05	0.000395	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.61e-05	0.000387	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.58e-05	0.000379	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.55e-05	0.000372	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.54e-05	0.00037	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCG2—epilepsy syndrome	1.5e-05	0.000362	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.5e-05	0.000361	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—AGT—epilepsy syndrome	1.48e-05	0.000357	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2C19—epilepsy syndrome	1.47e-05	0.000353	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP11A1—epilepsy syndrome	1.46e-05	0.000351	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.45e-05	0.000348	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.45e-05	0.000348	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.43e-05	0.000343	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.4e-05	0.000338	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—JUNB—epilepsy syndrome	1.38e-05	0.000332	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.35e-05	0.000325	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.34e-05	0.000322	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPIA—epilepsy syndrome	1.32e-05	0.000318	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.32e-05	0.000317	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2D6—epilepsy syndrome	1.31e-05	0.000317	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.28e-05	0.000309	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.27e-05	0.000306	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.27e-05	0.000306	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ADRA2A—epilepsy syndrome	1.25e-05	0.000301	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	1.25e-05	0.000301	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC2A1—epilepsy syndrome	1.19e-05	0.000286	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.18e-05	0.000285	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLCB1—epilepsy syndrome	1.18e-05	0.000283	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TH—epilepsy syndrome	1.17e-05	0.000282	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.16e-05	0.000279	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.15e-05	0.000278	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.14e-05	0.000273	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.14e-05	0.000273	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.13e-05	0.000273	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	1.11e-05	0.000267	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—VDR—epilepsy syndrome	1.09e-05	0.000263	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.07e-05	0.000257	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	1.04e-05	0.00025	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.04e-05	0.000249	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.01e-05	0.000243	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1e-05	0.000241	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	1e-05	0.000241	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.95e-06	0.00024	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMOX1—epilepsy syndrome	9.78e-06	0.000235	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC2A1—epilepsy syndrome	9.77e-06	0.000235	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JUNB—epilepsy syndrome	9.7e-06	0.000234	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAT—epilepsy syndrome	9.65e-06	0.000232	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS1—epilepsy syndrome	9.63e-06	0.000232	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	9.56e-06	0.00023	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCB1—epilepsy syndrome	9.39e-06	0.000226	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.26e-06	0.000223	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.26e-06	0.000223	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.26e-06	0.000223	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HBEGF—epilepsy syndrome	9.19e-06	0.000221	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.07e-06	0.000219	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	9.05e-06	0.000218	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT3—epilepsy syndrome	9.02e-06	0.000217	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.91e-06	0.000215	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ADAM10—epilepsy syndrome	8.81e-06	0.000212	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPX1—epilepsy syndrome	8.73e-06	0.00021	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	8.61e-06	0.000207	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.61e-06	0.000207	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.61e-06	0.000207	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCHE—epilepsy syndrome	8.58e-06	0.000207	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDC42—epilepsy syndrome	8.23e-06	0.000198	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	8.18e-06	0.000197	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLCB1—epilepsy syndrome	8.09e-06	0.000195	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.09e-06	0.000195	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TH—epilepsy syndrome	8.06e-06	0.000194	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.87e-06	0.00019	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.67e-06	0.000185	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.67e-06	0.000185	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AGT—epilepsy syndrome	7.65e-06	0.000184	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HES1—epilepsy syndrome	7.53e-06	0.000181	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOE—epilepsy syndrome	7.5e-06	0.000181	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FYN—epilepsy syndrome	7.32e-06	0.000176	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.32e-06	0.000176	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.32e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—H2AFX—epilepsy syndrome	7.3e-06	0.000176	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.16e-06	0.000172	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—YWHAZ—epilepsy syndrome	7.04e-06	0.00017	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.02e-06	0.000169	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.88e-06	0.000166	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CCR5—epilepsy syndrome	6.77e-06	0.000163	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.75e-06	0.000163	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMOX1—epilepsy syndrome	6.73e-06	0.000162	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAT—epilepsy syndrome	6.64e-06	0.00016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCB1—epilepsy syndrome	6.46e-06	0.000156	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—epilepsy syndrome	6.44e-06	0.000155	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.32e-06	0.000152	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TSC2—epilepsy syndrome	6.3e-06	0.000152	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOE—epilepsy syndrome	6.16e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.13e-06	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPX1—epilepsy syndrome	6.01e-06	0.000145	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—epilepsy syndrome	5.87e-06	0.000141	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6ST—epilepsy syndrome	5.79e-06	0.000139	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—epilepsy syndrome	5.74e-06	0.000138	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.55e-06	0.000134	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.55e-06	0.000134	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AGT—epilepsy syndrome	5.27e-06	0.000127	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOE—epilepsy syndrome	5.16e-06	0.000124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—epilepsy syndrome	5.14e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF2—epilepsy syndrome	4.68e-06	0.000113	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.52e-06	0.000109	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—epilepsy syndrome	4.43e-06	0.000107	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.41e-06	0.000106	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.38e-06	0.000105	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTOR—epilepsy syndrome	4.26e-06	0.000103	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—epilepsy syndrome	4.04e-06	9.73e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.95e-06	9.52e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.76e-06	9.06e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.75e-06	9.02e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.57e-06	8.61e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.53e-06	8.51e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TH—epilepsy syndrome	3.52e-06	8.48e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SRC—epilepsy syndrome	3.41e-06	8.22e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—epilepsy syndrome	3.02e-06	7.26e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.94e-06	7.08e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.9e-06	6.98e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.82e-06	6.79e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.62e-06	6.32e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—epilepsy syndrome	2.58e-06	6.22e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.3e-06	5.54e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.25e-06	5.43e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—epilepsy syndrome	2.12e-06	5.11e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.94e-06	4.66e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.78e-06	4.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.77e-06	4.25e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.54e-06	3.72e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.76e-07	1.87e-05	CbGpPWpGaD
